Suven Life Sciences Limited (NSE:SUVEN) — Stock Price

Rs332.60 INR
▲ 4.46% today

Suven Life Sciences Limited (NSE:SUVEN) is currently trading at Rs332.60 INR, up 4.46% today. Over the past 52 weeks, shares have ranged between Rs126.65 and Rs359.55. This page tracks Suven Life Sciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Suven Life Sciences Limited.

Suven Life Sciences Limited (SUVEN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Suven Life Sciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Suven Life Sciences Limited Income Statement — Revenue, Profit & Earnings by Year

Suven Life Sciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs66.56 Million Rs116.93 Million Rs135.39 Million Rs118.44 Million Rs134.78 Million
Cost of Revenue Rs342.89 Million Rs8.24 Million Rs5.66 Million Rs255.75 Million Rs1.03 Million
Gross Profit Rs-276.33 Million Rs108.69 Million Rs129.74 Million Rs-137.31 Million Rs133.75 Million
Research & Development Rs1.44 Billion Rs1.14 Billion Rs1.15 Billion Rs1.06 Billion Rs710.27 Million
SG&A Rs26.41 Million Rs27.11 Million Rs25.35 Million Rs24.94 Million Rs22.87 Million
Total Operating Expenses Rs1.44 Billion Rs1.33 Billion Rs1.34 Billion Rs1.27 Billion Rs895.63 Million
Operating Income Rs-1.72 Billion Rs-1.23 Billion Rs-1.32 Billion Rs-1.26 Billion Rs-838.73 Million
EBITDA Rs-1.55 Billion Rs-992.78 Million Rs-1.11 Billion Rs-1.17 Billion Rs-721.87 Million
EBIT Rs-1.61 Billion Rs-1.06 Billion Rs-1.18 Billion Rs-1.21 Billion Rs-765.33 Million
Interest Expense Rs466.00K Rs2.98 Million Rs4.12 Million Rs6.68 Million Rs9.41 Million
Income Before Tax Rs-1.61 Billion Rs-1.06 Billion Rs-1.18 Billion Rs-1.22 Billion Rs-774.74 Million
Income Tax Expense — Rs-10.02 Million Rs86.53 Million Rs15.98 Million Rs-53.23 Million
Net Income Rs-1.61 Billion Rs-1.05 Billion Rs-1.18 Billion Rs-1.22 Billion Rs-721.51 Million

Suven Life Sciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Suven Life Sciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs1.35 Billion Rs2.85 Billion Rs3.89 Billion Rs1.08 Billion Rs1.28 Billion
Total Current Assets Rs754.72 Million Rs2.57 Billion Rs2.52 Billion Rs665.95 Million Rs1.03 Billion
Cash & Equivalents Rs227.01 Million — Rs1.47 Billion Rs-1.00K Rs369.20 Million
Short-term Investments Rs222.78 Million Rs759.35 Million Rs1.98 Billion Rs451.62 Million Rs370.06 Million
Net Receivables Rs14.12 Million Rs34.88 Million Rs135.84 Million Rs20.46 Million Rs454.95 Million
Inventory Rs2.38 Million Rs7.08 Million Rs79.00K Rs330.00K Rs6.39 Million
Property, Plant & Equipment Rs594.82 Million Rs280.10 Million Rs370.16 Million Rs408.90 Million Rs256.01 Million
Goodwill — — — — —
Total Liabilities Rs251.97 Million Rs148.62 Million Rs135.91 Million Rs118.89 Million Rs204.12 Million
Total Current Liabilities Rs234.86 Million Rs135.16 Million Rs111.30 Million Rs83.15 Million Rs159.09 Million
Long-term Debt — Rs0.00 Rs0.00 Rs0.00 Rs3.92 Million
Net Debt Rs-377.26 Million Rs-142.23 Million Rs-354.14 Million Rs-20.65 Million Rs-45.85 Million
Total Stockholder Equity Rs1.10 Billion Rs2.70 Billion Rs3.75 Billion Rs961.45 Million Rs1.08 Billion
Retained Earnings Rs-6.01 Billion Rs-4.40 Billion Rs-3.35 Billion Rs-2.17 Billion Rs-945.09 Million

Suven Life Sciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Suven Life Sciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs-1.48 Billion Rs-1.15 Billion Rs-1.03 Billion Rs-1.28 Billion Rs-960.24 Million
Capital Expenditures Rs372.76 Million Rs1.16 Billion Rs28.95 Million Rs197.72 Million Rs63.05 Million
Free Cash Flow Rs-1.86 Billion Rs-1.15 Billion Rs-1.06 Billion Rs-1.47 Billion Rs-1.02 Billion
Investing Cash Flow Rs1.49 Billion Rs944.36 Million Rs-2.61 Billion Rs-222.29 Million Rs558.40 Million
Financing Cash Flow Rs-7.10 Million Rs-10.54 Million Rs3.96 Billion Rs1.46 Billion Rs348.56 Million
Dividends Paid — — — — —
Stock-Based Compensation Rs12.74 Million Rs0.00 — — —
Depreciation Rs58.22 Million Rs58.16 Million Rs58.27 Million Rs35.64 Million Rs35.24 Million
Change in Cash Rs460.00K Rs-220.87 Million Rs317.45 Million Rs-40.75 Million Rs-53.27 Million

Suven Life Sciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Suven Life Sciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 11, 2026 — — —
Jan 22, 2026 — — —
Oct 27, 2025 — — —
Aug 04, 2025 — — —
May 13, 2025 — — —
Jan 28, 2025 — — —
Nov 10, 2022 -1.46 0.00 —
Jul 26, 2022 -1.12 0.00 —